---
schema_version: "secwatch.filing_event.v1"
accession: "0001438133-22-000257"
form_type: "8-K"
ticker: "TNDM"
cik: "0001438133"
company_name: "TANDEM DIABETES CARE INC"
filed_at: "2022-12-13T23:59:59+00:00"
generated_at: "2026-06-21T05:18:12.974910+00:00"
event_type: "m_and_a"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Tandem Diabetes Care to acquire AMF Medical (Sigi Patch Pump) for up to CHF 200M

## Summary
- Cash payment of CHF 62.4M at closing plus CHF 8M prior strategic investment; earnouts up to CHF 129.6M.
- Earnouts: CHF 38.4M upon key development milestones over next two years; CHF 91.2M upon FDA clearance of ACE pump.
- Transaction expected to close January 2023, subject to no material adverse effect and other customary conditions.
- Acquires Sigi Patch Pump technology, expanding insulin delivery pipeline for Tandem.

## SEC filing metadata
- accession: 0001438133-22-000257
- form_type: 8-K
- ticker: TNDM
- cik: 0001438133
- company_name: TANDEM DIABETES CARE INC
- filed_at: 2022-12-13T23:59:59+00:00
- event_type: m_and_a
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 1.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438133/000143813322000257/0001438133-22-000257-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438133/000143813322000257/tndm-20221210.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001438133-22-000257
- JSON: https://secwatch.observer/filing/0001438133-22-000257.json
- Plain text: https://secwatch.observer/filing/0001438133-22-000257.txt

## Key facts
- Material Agreements
  TANDEM DIABETES CARE INC entered into Share Purchase Agreement with the Sellers listed on Annex B attached thereto and AMF Medical SA valued at CHF 62.4 million (effective 2022-12-10).
  - Action: entry
  - Agreement: asset purchase
  - Counterparty: the Sellers listed on Annex B attached thereto and AMF Medical SA
  - Value: CHF 62.4 million
  - Effective: 2022-12-10
  source text: On December 10, 2022 , Tandem Diabetes Care, Inc., a Delaware corporation (the “Company”), entered into a Share Purchase Agreement (the “Purchase Agreement”) with the Sellers listed on Annex B attached thereto (collectively, the “Sellers” and each, individually, a “Seller”) and AMF Medical SA, a corporation organized and existing under the laws of Switzerland (“AMF Medical”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1438133/000143813322000257/0001438133-22-000257-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.